Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Authors
Keywords
-
Journal
CNS DRUGS
Volume 36, Issue 1, Pages 17-30
Publisher
Springer Science and Business Media LLC
Online
2021-11-18
DOI
10.1007/s40263-021-00877-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
- (2021) Natalie Hesselgrave et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey
- (2021) Arianna Patacchini et al. INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE
- Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
- (2020) Meghan Hibicke et al. ACS Chemical Neuroscience
- Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
- (2020) Lea J Mertens et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
- (2020) Simon B. Goldberg et al. PSYCHIATRY RESEARCH
- Role of Interleukin-6 in Depressive Disorder
- (2020) Emily Yi-Chih Ting et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extending the specificity of differential-reinforcement-of-low rate 72-s (DRL 72-s) behavior for screening antidepressant-like effects of glutamatergic clinically validated anxiolytic or antidepressant drugs in rats
- (2020) Gerard J Marek et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- (2020) N. L. Mason et al. NEUROPSYCHOPHARMACOLOGY
- The Role of BDNF on Neural Plasticity in Depression
- (2020) Tao Yang et al. Frontiers in Cellular Neuroscience
- The emerging role of psilocybin and MDMA in the treatment of mental illness
- (2020) Hartej Gill et al. Expert Review of Neurotherapeutics
- Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
- (2020) Thomas F. Varley et al. NEUROIMAGE
- A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?
- (2020) Seetal Dodd et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes
- (2020) Sanah M. Nkadimeng et al. Scientific Reports
- Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
- (2019) Thu Ha Pham et al. PHARMACOLOGY & THERAPEUTICS
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
- (2019) Ronald S. Duman et al. NEURON
- An update on NMDA antagonists in depression
- (2019) Bartłomiej Pochwat et al. Expert Review of Neurotherapeutics
- Classical psychedelics for the treatment of depression and anxiety: A systematic review
- (2019) Silvia Muttoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression
- (2019) Naji C. Salloum et al. JOURNAL OF AFFECTIVE DISORDERS
- DARK Classics in Chemical Neuroscience: Psilocybin
- (2018) Haden A. Geiger et al. ACS Chemical Neuroscience
- The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug
- (2018) Agnieszka Pałucha-Poniewiera Pharmacological Reports
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
- (2018) Todd D. Gould et al. Annual Review of Pharmacology and Toxicology
- Abnormal amygdala resting-state functional connectivity in adults and adolescents with major depressive disorder: A comparative meta-analysis
- (2018) Shi Tang et al. EBioMedicine
- Altered serum levels of TNF-α, IL-6, and IL-18 in depressive disorder patients
- (2017) Ni Fan et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effect of Psilocybin on Empathy and Moral Decision-Making
- (2017) Thomas Pokorny et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Treatment-Resistant Depression in Primary Care across Canada
- (2017) Sakina J Rizvi et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
- (2016) Ji-chun Zhang et al. Current Neuropharmacology
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
- (2016) N Kappelmann et al. MOLECULAR PSYCHIATRY
- BDNF – a key transducer of antidepressant effects
- (2016) Carl Björkholm et al. NEUROPHARMACOLOGY
- Inflammation, Glutamate and Glia: A Trio of Trouble in Mood Disorders
- (2016) Ebrahim Haroon et al. NEUROPSYCHOPHARMACOLOGY
- Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions
- (2016) W. Rief et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients
- (2016) Yayan Luo et al. PSYCHIATRY RESEARCH
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- The dose makes the poison: from glutamate-mediated neurogenesis to neuronal atrophy and depression
- (2016) Alberto Rubio-Casillas et al. REVIEWS IN THE NEUROSCIENCES
- Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
- (2015) Adam L. Halberstadt BEHAVIOURAL BRAIN RESEARCH
- Default mode network dissociation in depressive and anxiety states
- (2015) Joana Fernandes Coutinho et al. Brain Imaging and Behavior
- A brief history of the development of antidepressant drugs: From monoamines to glutamate.
- (2015) Todd M. Hillhouse et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
- (2014) Attila Szabo et al. PLoS One
- Inflamed moods: A review of the interactions between inflammation and mood disorders
- (2014) Joshua D. Rosenblat et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Spatiotemporal Brain Dynamics of Emotional Face Processing Modulations Induced by the Serotonin 1A/2A Receptor Agonist Psilocybin
- (2013) F. Bernasconi et al. CEREBRAL CORTEX
- Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression
- (2013) Gianluca Serafini et al. CURRENT PHARMACEUTICAL DESIGN
- Psilocybin – Summary of knowledge and new perspectives
- (2013) Filip Tylš et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
- (2013) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
- (2013) M. Kometer et al. JOURNAL OF NEUROSCIENCE
- Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
- (2013) Felix Nau et al. PLoS One
- Neuronal plasticity and antidepressant actions
- (2013) Eero Castrén et al. TRENDS IN NEUROSCIENCES
- Animal Models of Serotonergic Psychedelics
- (2012) James B. Hanks et al. ACS Chemical Neuroscience
- Functional Neuroimaging of Major Depressive Disorder: A Meta-Analysis and New Integration of Baseline Activation and Neural Response Data
- (2012) J. Paul Hamilton et al. AMERICAN JOURNAL OF PSYCHIATRY
- Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
- (2012) Michael Kometer et al. BIOLOGICAL PSYCHIATRY
- Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A·mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function
- (2012) José L. Moreno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms
- (2012) P. R. Albert et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Hallucinogen actions on human brain revealed
- (2012) H.-M. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- (2011) Adam L. Halberstadt et al. NEUROPHARMACOLOGY
- Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
- (2011) Boris B Quednow et al. NEUROPSYCHOPHARMACOLOGY
- Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
- (2011) José L. Moreno et al. NEUROSCIENCE LETTERS
- Structural and synaptic plasticity in stress-related disorders
- (2011) Daniel J. Christoffel et al. REVIEWS IN THE NEUROSCIENCES
- Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells
- (2010) Kumiko Tanabe et al. Journal of Neuroinflammation
- Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a -Arrestin2/Src/Akt Signaling Complex In Vivo
- (2010) C. L. Schmid et al. JOURNAL OF NEUROSCIENCE
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- Depression, rumination and the default network
- (2010) Marc G. Berman et al. Social Cognitive and Affective Neuroscience
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Cytokine, Sickness Behavior, and Depression
- (2009) Robert Dantzer IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Depression, traumatic stress and interleukin-6
- (2009) Petr Bob et al. JOURNAL OF AFFECTIVE DISORDERS
- BDNF downregulates 5-HT2A receptor protein levels in hippocampal cultures
- (2009) V. Trajkovska et al. NEUROCHEMISTRY INTERNATIONAL
- The TNF-α System: Functional Aspects in Depression, Narcolepsy and Psychopharmacology
- (2008) Mark Berthold-Losleben et al. Current Neuropharmacology
- Identification of a serotonin/glutamate receptor complex implicated in psychosis
- (2008) Javier González-Maeso et al. NATURE
- Effects of varied doses of psilocybin on time interval reproduction in human subjects
- (2008) Jiří Wackermann et al. NEUROSCIENCE LETTERS
- Agonist-directed signaling of the serotonin 2A receptor depends on -arrestin-2 interactions in vivo
- (2008) C. L. Schmid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now